Recent Articles from MarketBeat
MarketBeat is an American financial media company headquartered in Sioux Falls, South Dakota, founded in 2011 by Matthew Paulson as Analyst Ratings Network before rebranding in 2015. The company operates an online platform that delivers real-time financial data, market analysis, and news, aiming to empower individual investors with tools to make informed trading decisions.
Website: https://www.marketbeat.com
Cumberland Pharmaceuticals Begins Rolling FDA NDA for Dyscorban in Duchenne Cardiomyopathymarketbeat.com
Cumberland Pharmaceuticals (NASDAQ:CPIX) said it plans to begin a rolling New Drug Application submission for Dyscorban, its ifetroban candidate for cardiomyopathy associated with Duchenne muscular dystrophy, after the U.S. Food and Drug Administration granted the company’s request for rolling revie
Via MarketBeat · October 26, 2026
Resources Connection Shareholders Approve All Proposals, Re-Elect Carlilemarketbeat.com
Resources Connection (NASDAQ:RGP) shareholders approved all five proposals presented at the company’s 2026 annual meeting, including the re-election of Chairman, President and Chief Executive Officer Roger D. Carlile and director Marco von Maltzan.
The virtual meeting was held with holders of 78.7%
Via MarketBeat · October 26, 2026
TuHURA Reports Early Responses in Deep-Seated Merkel Cell Cancer Studymarketbeat.com
TuHURA Biosciences (NASDAQ:HURA) presented preliminary results from its ongoing open-label Phase 1b study of IFx-2.0 in patients with metastatic Merkel cell carcinoma, or MCC, reporting confirmed partial responses in the first three evaluable patients treated in the frontline setting.
Speaking duri
Via MarketBeat · October 26, 2026
Bank of Hawaii Q3 Earnings Call Highlightsmarketbeat.com
Bank of Hawaii (NYSE:BOH) reported third-quarter 2026 net income of $64.3 million, or $1.49 per diluted share, as higher net interest income and continued asset repricing supported earnings growth. Net income rose 1.4% from the prior quarter and 20.5% from the third quarter of 2025, while diluted ea
Via MarketBeat · October 26, 2026
River City Bank Q3 Earnings Call Highlightsmarketbeat.com
River City Bank (NASDAQ:RCBC) reported third-quarter net income of $30.6 million, or $2.16 per share, in its first earnings release as a public company following its August Nasdaq initial public offering. The reported results included a $17.1 million pre-tax gain from changes in the fair value of un
Via MarketBeat · October 26, 2026
Xencor Picks Phase 3 Dose After XmAb819 Shows 45.5% Response Rate in Kidney Cancermarketbeat.com
Xencor (NASDAQ:XNCR) reported updated Phase 1 dose-expansion results for its ENPP3-targeting CD3 T-cell engager, XmAb819, in previously treated advanced clear cell renal cell carcinoma at the ESMO 2026 conference. The company said it selected a 400 microgram-per-kilogram intravenous target dose for
Via MarketBeat · October 26, 2026
What Consumer Portfolio Services (CPSS) Said on Its Q3 Earnings Callmarketbeat.com
Consumer Portfolio Services (NASDAQ:CPSS) reported higher third-quarter revenue, earnings and record originations as the company expanded its sales force and dealer network while maintaining what management described as a disciplined credit approach.
Chief Executive Officer Charles Bradley called t
Via MarketBeat · October 26, 2026
Comfort Systems Earnings: AI Slowdown or More Growth Ahead?marketbeat.com
Comfort Systems USA posted record Q3 revenue and backlog, but declining gross margins and vague 2027 guidance triggered a sharp sell-off amid broader AI trade concerns.
Via MarketBeat · October 26, 2026
C3.ai Shareholders Approve Directors, Pay, Auditor and Equity Plan at Annual Meetingmarketbeat.com
C3.ai (NYSE:AI) stockholders approved all four proposals presented at the company’s 2026 annual meeting, including the election of three Class III directors, an advisory vote on executive compensation, the appointment of Deloitte & Touche as auditor, and an amendment and restatement of the compa
Via MarketBeat · October 26, 2026
What Coca Cola Femsa (KOF) Said on Its Q3 Earnings Callmarketbeat.com
Coca Cola Femsa (NYSE:KOF) reported record third-quarter volume, with consolidated unit case volume rising 5.3% year over year to 1.1 billion. Revenue increased 10.9% to MXN 79.7 billion, while majority net income rose 5.5% to MXN 6.2 billion.
CEO Ian Craig said the company’s results reflected comm
Via MarketBeat · October 26, 2026
What Cemex (CX) Said on Its Q3 Earnings Callmarketbeat.com
Cemex (NYSE:CX) reported third-quarter 2026 results marked by higher sales, expanding profitability and stronger cash generation, as the building materials company said its Project Cutting Edge transformation program continued to produce savings and operational improvements.
Chief Executive Officer
Via MarketBeat · October 26, 2026
What Bank of Marin Bancorp (BMRC) Said on Its Q3 Earnings Callmarketbeat.com
Bank of Marin Bancorp (NASDAQ:BMRC) reported higher third-quarter earnings as net interest margin expanded, loan production improved and non-interest-bearing deposits increased.
Net income for the quarter ended September 30, 2026, was $9.9 million, or $0.62 per share, compared with $9.2 million, or
Via MarketBeat · October 26, 2026
Bristol Myers Squibb's Cancer Breakthrough Could Have Implications Beyond Its Own Stockmarketbeat.com
Bristol-Myers Squibb's iza-bren cut breast cancer progression risk by up to 38% in a Phase 3 trial, lifting shares and raising implications for rivals like Exelixis.
Via MarketBeat · October 26, 2026
5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Capsmarketbeat.com
Teradyne, Grail, Kratos Defense, FormFactor and Fabrinet have pulled back despite strong growth, setting up potential entry points in robotics, quantum and AI.
Via MarketBeat · October 26, 2026
Alnylam Reports Up to 83% Huntingtin Reduction, Eyes 2027 Pivotal Trialmarketbeat.com
Alnylam Pharmaceuticals (NASDAQ:ALNY) outlined early clinical data for brezosiran, an investigational RNA interference therapy for Huntington’s disease, reporting dose-dependent reductions in cerebrospinal fluid mutant huntingtin after a single intrathecal dose and plans to begin a placebo-controlle
Via MarketBeat · October 26, 2026
Easterly Government Properties Q3 Earnings Call Highlightsmarketbeat.com
Easterly Government Properties (NYSE:DEA) reported third-quarter 2026 core funds from operations growth and raised the low end of its full-year guidance, while outlining a 2027 outlook that incorporates refinancing pressure and the expected departure of a Federal Aviation Administration tenant in Ch
Via MarketBeat · October 26, 2026
Business First Bancshares Q3 Earnings Call Highlightsmarketbeat.com
Business First Bancshares (NASDAQ:BFST) reported third-quarter results that management said reflected stronger loan and deposit growth, continued net interest margin expansion and lower core expenses following the integration of Progressive Bank.
GAAP net income available to common shareholders tot
Via MarketBeat · October 26, 2026
Anthropic's IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giantsmarketbeat.com
Anthropic's IPO filing reveals $224.5 billion in non-cancelable compute deals with Amazon and Alphabet, highlighting NVIDIA and Broadcom as key beneficiaries of AI infrastructure spending.
Via MarketBeat · October 26, 2026
Insiders Are Selling These 5 AI Stocks—Should You Worry?insidertrades.com
Insiders at CoreWeave, Arista Networks, Dell, Snowflake and NVIDIA have been selling shares, but analyst ratings, institutional buying and fundamentals suggest the AI trade's outlook remains largely intact.
Via MarketBeat · October 26, 2026
Buy the Dip: 4 Stocks the Market Marked Down Too Far Ahead of Big Catalystsmarketbeat.com
MercadoLibre, Novo Nordisk, Tyler Technologies and Summit Therapeutics trade below recent highs, yet each has earnings or catalysts that could shift sentiment.
Via MarketBeat · October 26, 2026
Range Resources to Join EQT in $50B Appalachian Gas Dealmarketbeat.com
EQT Corp. announced an agreement to acquire Range Resources (NYSE:RRC) in an all-stock transaction that the companies said would create a larger, vertically integrated Appalachian natural gas platform focused on serving anticipated growth in domestic power generation, pipeline takeaway and internati
Via MarketBeat · October 26, 2026
Verizon Communications Q3 Earnings Call Highlightsmarketbeat.com
Verizon Communications (NYSE:VZ) reported stronger third-quarter operating and financial results, citing growth in postpaid wireless accounts, lower customer-acquisition costs, accelerating service-revenue growth and rising free cash flow. The company raised several elements of its 2026 outlook and
Via MarketBeat · October 26, 2026
What Alliance Resource Partners (ARLP) Said on Its Q3 Earnings Callmarketbeat.com
Alliance Resource Partners (NASDAQ:ARLP) reported higher third-quarter 2026 revenue, earnings and adjusted EBITDA, supported by stronger coal shipments, the return of longwall production at its Hamilton mine and the first full-quarter contribution from its AllDale III and IV oil-and-gas royalty acqu
Via MarketBeat · October 26, 2026
Amur Minerals H1 Earnings Call Highlightsmarketbeat.com
Airtel Money reported strong first-half growth in its first results presentation since listing on the London Stock Exchange, with revenue rising 34% in reported currency to $830 million and 25.1% in constant currency.
The mobile financial services provider, which operates across 13 markets in East
Via MarketBeat · October 26, 2026
3 Companies With Room to Pass on Costs to Manage Inflationmarketbeat.com
As inflation accelerates, WD-40, Balchem, and Interparfums show pricing power and sales resilience despite rising chemical, freight, and logistics costs pressuring margins.
Via MarketBeat · October 26, 2026
EQT to Acquire Range Resources in $50B Natural Gas Powerhouse Dealmarketbeat.com
EQT (NYSE:EQT) announced an agreement to acquire Range Resources in an all-stock transaction that the companies said would create a larger integrated natural gas producer with expanded Appalachian Basin inventory, infrastructure access and marketing capabilities.
Under the agreement, Range sharehol
Via MarketBeat · October 26, 2026
What Medifast (MED) Said on Its Q3 Earnings Callmarketbeat.com
Medifast (NYSE:MED) reported third-quarter 2026 revenue of $72 million, down 19.4% from a year earlier, as the company continued to face a sharp decline in its active earning coach base. Management said revenue was within its guidance range and marked a fourth consecutive quarter in which sales stab
Via MarketBeat · October 26, 2026
MakeMyTrip Q2 Earnings Call Highlightsmarketbeat.com
MakeMyTrip (NASDAQ:MMYT) reported 20.9% year-over-year growth in second-quarter fiscal 2027 gross bookings on a constant-currency basis, reaching $2.7 billion, as growth in hotels, ground transportation and ancillary services helped offset pressure on air travel.
Co-Founder and Group CEO Rajesh Mag
Via MarketBeat · October 26, 2026
Not All Tech Is Getting Crushed: 5 Names Holding Up Through the AI Sell-Offmarketbeat.com
While chip stocks slide, cybersecurity and software names like HACK, IGV, Microsoft, CrowdStrike, and Palantir hold near highs, suggesting a rotation within tech rather than a broad exit.
Via MarketBeat · October 26, 2026
Actively Managed ETFs Are Giving In to the Price War—To the Benefit of Investorsmarketbeat.com
Low-fee active ETFs DFLV, DFAC, and USMC now rival passive funds on cost, but comparisons with Vanguard alternatives show mixed performance and liquidity trade-offs for investors.
Via MarketBeat · October 26, 2026
Valero’s Windfall Quarter Meets Washington’s Push for Cheaper Dieselmarketbeat.com
Valero posted record Q3 revenue and EPS on soaring refining margins, but shares sold off on light Q4 guidance and concerns over Russian diesel imports and crude price pressure.
Via MarketBeat · October 26, 2026
Acumen Pharmaceuticals Q3 Earnings Call Highlightsmarketbeat.com
Acumen Pharmaceuticals (NASDAQ:ABOS) said it expects to report top-line results in November from its Phase II ALTITUDE-AD trial of sabirnetug, an investigational antibody designed to target soluble amyloid-beta oligomers in patients with Alzheimer’s disease.
Chief Executive Officer Dan O’Connell sa
Via MarketBeat · October 26, 2026
Lockheed Martin, Interactive Brokers, AEP Hike Dividends on Strong Growthdividendstocks.com
Lockheed Martin, Interactive Brokers and American Electric Power raised dividends, with payout ratios near or below 60% pointing to sustainable future increases.
Via MarketBeat · October 26, 2026
4 Small-Cap Stocks With Paths to Recovery After the Fed's September Rate Hikemarketbeat.com
Amid a Russell 2000 sell-off driven by rising rates, FIBK, EPAC, CCS, and HRMY show varied resilience, with analysts weighing risks against potential upside in each stock.
Via MarketBeat · October 26, 2026
A 70% Rally Isn't Chord Energy's Only Selling Pointmarketbeat.com
Chord Energy shares have surged over 70% in 2026 on higher oil prices and strong free cash flow, fueling dividends and buybacks ahead of its Nov. 4 earnings report.
Via MarketBeat · October 26, 2026
Broadcom's AI Chip Business Is Booming, But Alphabet's Strategy Highlights 2 Key Risksmarketbeat.com
Broadcom faces rising competition as Alphabet diversifies its TPU suppliers to MediaTek, though growing Anthropic and OpenAI demand could offset this risk to AVGO's AI chip growth.
Via MarketBeat · October 26, 2026
Amazon's $350 Price Target Faces a Big Earnings Testmarketbeat.com
Morgan Stanley named Amazon its Top Pick with a $350 target, citing AWS growth, but shares have slipped ahead of the Oct. 29 earnings report amid AI spending worries.
Via MarketBeat · October 26, 2026
NORMA Group Unveils New Strategy Targeting 10%+ EBIT Margin by 2031marketbeat.com
NORMA Group (ETR:NOEJ) outlined its “New NORMA” strategy at its first capital markets day since the company’s 2011 initial public offering, setting targets for profitable growth, margin expansion and cash generation through 2031.
Chief Executive Officer Birgit Seeger said the company is reorganizin
Via MarketBeat · October 25, 2026
Rapport Therapeutics’ RAP-219 Hits Phase II Goals in Bipolar Mania Trialmarketbeat.com
Rapport Therapeutics (NASDAQ:RAPP) reported positive top-line results from a Phase II proof-of-concept trial of RAP-219 in adults with acute bipolar mania, meeting both its primary and secondary endpoints and supporting plans to advance the candidate into Phase III development.
The three-week, plac
Via MarketBeat · October 25, 2026
Newmont’s Record Quarter Shows Why Gold’s Floor Is the Real Storymarketbeat.com
Newmont posted record Q3 adjusted earnings of $2.20 per share as gold held near a $4,000 floor, with improved cost guidance, strong free cash flow, buybacks, and dividends.
Via MarketBeat · October 25, 2026
Odyssey Therapeutics Highlights OD-001 Phase IIa UC Data, Sets 2027 Trial Readoutsmarketbeat.com
Odyssey Therapeutics (NASDAQ:ODTX) presented additional data from its open-label Phase IIa trial of OD-001, an oral RIPK2 scaffolding inhibitor for moderate-to-severe ulcerative colitis, during its UEG Week 2026 investor webcast. The company said the complete induction dataset, biomarker findings an
Via MarketBeat · October 25, 2026
Albemarle Upgrade: Can Energy Storage Recharge Lithium’s Leader?marketbeat.com
Mizuho upgraded Albemarle to Outperform with a $130 target, citing battery storage demand and low-cost production ahead of its Nov. 4 earnings report.
Via MarketBeat · October 25, 2026
Aclara Resources Targets Rare-Earth Supply Chain From South America to Louisianamarketbeat.com
Aclara Resources (TSE:ARA) outlined plans to build an integrated rare-earth supply chain spanning two ionic-clay deposits in South America, a separation facility in Louisiana and a metals-and-alloys operation, with management emphasizing its focus on heavy rare earth elements including dysprosium, t
Via MarketBeat · October 25, 2026
Consumer Staples Are Up 12% This Year—These 3 Beverage Stocks Are Leading the Waymarketbeat.com
Coca-Cola, Monster Beverage, and Keurig Dr. Pepper have each gained at least 20% YTD as beverages lead a consumer staples rebound, with all three reporting Q3 2026 earnings soon.
Via MarketBeat · October 25, 2026
Lexeo Therapeutics Maps Gene Therapy Milestones, Eyes Key 2027 Readoutmarketbeat.com
Lexeo Therapeutics (NASDAQ:LXEO) outlined upcoming clinical and regulatory milestones for its gene therapy programs in Friedreich’s ataxia cardiomyopathy and PKP2-associated arrhythmogenic cardiomyopathy during the Chardan Healthcare Conference.
Chief Financial Officer Lou Tamayo said the clinical-
Via MarketBeat · October 25, 2026
Can Planet Fitness Get Its Growth Back in Shape?marketbeat.com
Planet Fitness shares have slumped amid slowing membership growth and AI-related concerns, but analysts see over 30% upside ahead of third-quarter earnings on Nov. 5.
Via MarketBeat · October 25, 2026
3 Defined Outcome ETFs Offering Unique Twists on Buffer Strategiesmarketbeat.com
New defined outcome ETFs QBKV, SBAR, and XX offer varied buffer, income, and leveraged strategies tied to small caps, options income, and the S&P 500, each with distinct costs and risks.
Via MarketBeat · October 25, 2026
Opus Genetics Eyes 2029 Runway as Presbyopia Drop Wins FDA Approvalmarketbeat.com
Opus Genetics (NASDAQ:IRD) outlined commercialization expectations for its newly approved presbyopia eye drop, progress across its inherited retinal disease gene therapy pipeline and its funding strategy during an investor panel featuring Chief Executive Officer Dr. George Magrath and Chief Financia
Via MarketBeat · October 25, 2026
Market Volatility Playbook: Trade the Noise, Get Paid to Ignore the Restmarketbeat.com
Monument Traders Alliance strategists detail a volatility-trading sleeve using IWM, QQQ and GLD options alongside longer-term holdings in Agnico Eagle Mines and Nuveen Municipal Value Fund for income.
Via MarketBeat · October 25, 2026
Deep Fission Targets 2027 Kansas Nuclear Pilot, 2028 Commercial Rolloutmarketbeat.com
Deep Fission (NASDAQ:FISN) outlined its development, regulatory and financing plans for underground nuclear power projects during its October 2026 business update, targeting initial commercial power from a pilot project in Parsons, Kansas, by December 2027 and broader deployments beginning in 2028.
Via MarketBeat · October 25, 2026
Adagene Eyes Phase II Data for Masked CTLA-4 Therapy in MSS Colorectal Cancermarketbeat.com
Adagene (NASDAQ:ADAG) is advancing its masked anti-CTLA-4 antibody, ADG126, also known as muzastotug, in metastatic microsatellite-stable colorectal cancer (MSS CRC) and in a neoadjuvant investigator-sponsored trial in Singapore, Chief Strategy Officer Mickael Chane-Du said during a Chardan conferen
Via MarketBeat · October 25, 2026
Capstone Energy+ Eyes Data Centers With ‘Energy Certainty’ Pushmarketbeat.com
Capstone Energy+ (NASDAQ:CEPL) is positioning its distributed energy technology as a way to provide “energy certainty” for customers facing grid constraints, permitting delays and growing power needs, President and CEO Vince Canino said during a company presentation.
Canino said businesses historic
Via MarketBeat · October 25, 2026
Palvella Therapeutics Eyes QTORIN Launch as Rare-Disease Pipeline Expandsmarketbeat.com
Palvella Therapeutics (NASDAQ:PVLA) is preparing for a potential commercial launch of QTORIN rapamycin while advancing additional rare skin and vascular anomaly programs, Chief Financial Officer Matt Korenberg said during a Chardan investor session.
Korenberg said the company has expanded from deve
Via MarketBeat · October 25, 2026
OmniAb Highlights $3B Milestone Pipeline, AI Antibody Platform at Conferencemarketbeat.com
OmniAb (NASDAQ:OABI) Chief Financial Officer Kurt Gustafson outlined the company’s antibody-discovery platform, partner pipeline and revenue model during a company presentation, emphasizing a strategy built around licensing technology to pharmaceutical and biotechnology companies rather than develop
Via MarketBeat · October 25, 2026
FitLife Brands Eyes Acquisitions, Margin Gains to Offset Organic Growth Headwindsmarketbeat.com
FitLife Brands (NASDAQ:FTLF) outlined its strategy to grow a portfolio of nutritional supplement and wellness brands through acquisitions, e-commerce sales and operational improvements, while acknowledging recent organic-growth headwinds tied to Amazon changes, specialty retail traffic and weakening
Via MarketBeat · October 24, 2026
Strawberry Fields REIT CEO Maps SNF Growth Strategy, 100% Rent Collection Recordmarketbeat.com
Strawberry Fields REIT (NYSEAMERICAN:STRW) Chairman, CEO and founder Moishe Gubin outlined the skilled nursing facility real estate investment trust’s growth strategy, lease structure and demographic outlook, emphasizing recurring rent collections and a disciplined acquisition model.
Gubin said the
Via MarketBeat · October 24, 2026
Amgen's IMDELLTRA Cuts Death Risk 58% in Small-Cell Lung Cancer Studymarketbeat.com
Amgen (NASDAQ:AMGN) presented Phase III data at the European Society for Medical Oncology Congress 2026 showing that its DLL3-targeting BiTE therapy IMDELLTRA, when added to durvalumab maintenance treatment, improved survival outcomes for patients with extensive-stage small-cell lung cancer whose di
Via MarketBeat · October 24, 2026
Moderna Melanoma Therapy Cuts Recurrence Risk 42% in Phase 3 Trialmarketbeat.com
Moderna (NASDAQ:MRNA) presented Phase 3 results for intismeran, its individualized neoantigen therapy, in combination with Merck’s pembrolizumab for patients with resected high-risk melanoma. The INTerpath-001 trial met its primary endpoint of relapse-free survival and a key secondary endpoint of di
Via MarketBeat · October 24, 2026
Parabilis Highlights 72% Response Rate, Maps Phase III Desmoid Trial for 2027marketbeat.com
Parabilis Medicines (NASDAQ:PBLS) presented updated interim phase I/II data for investigational beta-catenin/TCF inhibitor zolucatetide in desmoid tumors at the European Society for Medical Oncology Congress in Madrid, reporting tumor responses, disease control and an FDA-aligned plan for a registra
Via MarketBeat · October 24, 2026
CitroTech Targets Wildfire Defense Growth With Hexion JV, CitroSafe Pushmarketbeat.com
CitroTech (NYSEAMERICAN:CITR) is positioning its citric-acid-derived fire-retardant technology for use in wildfire prevention, wood products and residential property protection, Chief Executive Officer Wes Bolsen said during a presentation at the LD Micro conference.
Bolsen, who became CEO about a
Via MarketBeat · October 24, 2026
Lotus Technology Targets EBIT Profitability Before 2030 as Deliveries, Margins Improvemarketbeat.com
Lotus Technology (NASDAQ:LOT) CFO Daxue Wang outlined the luxury automaker’s electrification strategy, first-half performance improvements and longer-term profitability targets during a company presentation.
Wang said Lotus, founded in 1948, is seeking to build on its heritage in Formula 1, sports
Via MarketBeat · October 24, 2026
BUDA Details Ultra Fresh Expansion, New Plants and Wholesale Growth Strategymarketbeat.com
BUDA (NYSEAMERICAN:BUDA) outlined its strategy to expand distribution of its “Ultra Fresh” juice and beverage products, emphasizing a wholesale model, a refrigerated supply chain and plans to add production capacity in the eastern and western United States.
During a company presentation, management
Via MarketBeat · October 24, 2026
Bloom Energy Just Reported—Its Biggest Order Is Still Waiting on a Pipelinemarketbeat.com
Bloom Energy's Q3 revenue surged 138.9% and guidance rose again despite Oracle's force majeure notice, as backlog growth, new deals, and analyst upside offset dilution risks.
Via MarketBeat · October 24, 2026
MLP Raises 2026 EBIT Outlook After Record Q3 Performance Feesmarketbeat.com
MLP (ETR:MLP) CFO Reinhard Loose outlined the financial services group’s growth strategy, reported first-half gains across its three core business areas and raised the company’s 2026 EBIT outlook following stronger-than-expected performance fees in the third quarter.
Loose said MLP’s business model
Via MarketBeat · October 24, 2026
Why Western Digital's AI Storage Boom Defies the Chip Sell-Offmarketbeat.com
Western Digital shares fell amid a chip sell-off despite rising margins, revenue growth, and strong demand for its hard disk drives, as the company posted higher guidance and a dividend increase.
Via MarketBeat · October 24, 2026
Tharimmune Investor Update Spotlights Canton Network’s Tokenization Pushmarketbeat.com
Canton Strategic Holdings President Mark Toomey said institutional participation in the Canton Network continued to expand during the third quarter as infrastructure providers, asset issuers and market participants prepared for a planned late-October rollout by the Depository Trust & Clearing Co
Via MarketBeat · October 24, 2026
Grand Canyon Education Strengthens Its Outlook, But Wall Street Remains Dividedmarketbeat.com
Grand Canyon Education posts steady enrollment and earnings growth, extends its GCU services agreement through 2041, but faces a CFO leave of absence and ongoing regulatory scrutiny.
Via MarketBeat · October 24, 2026
FST Conference: KBS Golf Shaft Maker Swings to Profit as Revenue Rises 23%marketbeat.com
FST (NASDAQ:KBSX), a golf shaft manufacturer operating under the KBS brand, said it increased first-half revenue by 23% and gross profit by 33% year over year as it benefited from manufacturing scale and lower per-shaft production costs.
Speaking at a company presentation, Chief Financial Officer S
Via MarketBeat · October 24, 2026
Amex Stock Slides on Job Cuts, But the Real Story Is Macromarketbeat.com
American Express posted record Q3 2026 revenue, raised EPS guidance, and improved credit metrics, yet AXP stock fell as investors weighed job cuts and macro concerns.
Via MarketBeat · October 24, 2026
Chefs' Warehouse Has Rallied 76%—Can the Stock Keep Climbing?marketbeat.com
Chefs' Warehouse shares are up 76% in 2026 on strong sales and profit growth, but a rich valuation and limited analyst upside raise questions about the stock's run.
Via MarketBeat · October 24, 2026
MarketBeat Week in Review – 10/19 - 10/23marketbeat.com
A market sell-off spread beyond tech as oil prices surged and AI concerns grew. MarketBeat analysts recap the week's top stories on earnings, from Halliburton to Meta Platforms and General Motors.
Via MarketBeat · October 24, 2026
CapsoVision Maps AI Capsule Push Into Colon, Pancreatic Cancer Screeningmarketbeat.com
CapsoVision (NASDAQ:CV) outlined its strategy to expand capsule endoscopy technology beyond its current small-bowel business into colon, pancreatic and esophageal cancer screening applications, highlighting its artificial intelligence capabilities, cloud-based workflow and upcoming regulatory submis
Via MarketBeat · October 24, 2026
Lexeo Therapeutics Eyes NSVT Data as Key Test for LX2020 Gene Therapymarketbeat.com
Lexeo Therapeutics (NASDAQ:LXEO) outlined its approach to evaluating LX2020, an investigational AAVrh10-based gene therapy for PKP2-associated arrhythmogenic cardiomyopathy, or ACM, ahead of an expected clinical and regulatory update later this quarter.
CEO Nolan Townsend said PKP2 ACM is a serious
Via MarketBeat · October 24, 2026
BlockchAIn Digital Infrastructure Unveils $1B+ Nebius Data Center Lease Strategymarketbeat.com
BlockchAIn Digital Infrastructure (NYSEAMERICAN:AIB) outlined a data-center development strategy centered on smaller, power-secured facilities, long-term tenant contracts and project-level financing during a presentation by CFO Jolienne Halisky.
Halisky said the company views itself as a “right-siz
Via MarketBeat · October 24, 2026
Kits Eyecare Eyes Glasses-Led Growth as Margins Expand and Capacity Rampsmarketbeat.com
Kits Eyecare (TSE:KITS) is targeting further growth in the online optical market by expanding its higher-margin glasses business, increasing brand awareness through select physical locations and leveraging a manufacturing operation that management says has substantial unused capacity.
Speaking at a
Via MarketBeat · October 24, 2026